Hims Says Failed Wegovy Collab Doesn't Merit Investor Suit

By Sydney Price · March 20, 2026, 5:36 PM EDT

Telehealth company Hims & Hers Health Inc. urged a California federal court to release it from a shareholder suit accusing it of exploiting its partnership with Novo Nordisk, the distributor of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Sookdeo v. Hims & Hers Health, Inc. et al

Case Number

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

June 25, 2025

Recent Articles By Sydney

March 18, 2026
SelectQuote Looks To Escape Investors' Kickback Probe Suit
March 05, 2026
Drugmaker Aquestive Hit With Suit Over FDA Approval Delay
March 03, 2026
BioAge Investors Lose Last Bid At Obesity Drug-Linked Suit
February 03, 2026
Masimo Investors' $34M Deal In Revenue Suit Gets Initial OK
January 30, 2026
SelectQuote Execs Face Investor Suit Over Kickback Probe
January 16, 2026
SEC Fines Biopharma Co. Execs Over Hidden FDA Findings
January 16, 2026
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit
January 09, 2026
Ex-Doximity Exec Cops To $2.5M Insider Trading Scheme
January 08, 2026
Ardent Health Investors Sue Over Revenue Accounting Issues
December 12, 2025
Molina Investor Sues Board Over Insurer's Guidance Cuts